Captial I. 2017 Ltd F2 serves as Executive at TCR2 THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Captial I. 2017 Ltd F2 has executed 9 insider transactions totaling $10.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 19, 2019 involved exercising options for 193,742 shares valued at $0.
Captial I. 2017 Ltd F2 currently holds 193,742 shares of TCR2 THERAPEUTICS INC. (TCRR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Captial I. 2017 Ltd F2 has been a net buyer of TCRR stock. They have purchased $10.0M and sold $0 worth of shares.
Captial I. 2017 Ltd F2's most recent insider trade was on Feb 19, 2019, when they sold 193,742 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $15.00 |
| Discretionary |
| Feb 19, 2019 | TCRR | $2.0M | Purchase | 133,333 | $15.00 | Discretionary |
| Feb 19, 2019 | TCRR | $0 | Conversion | 1,614,515 | $N/A | Discretionary |
| Feb 19, 2019 | TCRR | $2.5M | Purchase | 166,667 | $15.00 | Discretionary |
| Feb 19, 2019 | TCRR | $0 | Conversion | 410,168 | $N/A | Discretionary |
| Feb 19, 2019 | TCRR | $0 | Conversion | 282,540 | $N/A | Discretionary |
| Feb 19, 2019 | TCRR | $0 | Conversion | 403,629 | $N/A | Discretionary |
| Feb 19, 2019 | TCRR | $3.0M | Purchase | 200,000 | $15.00 | Discretionary |